CAI Q1 2016 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q1 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M+14.5% YoY

Gross Profit

$37M55.2% margin

Operating Income

$19M28.7% margin

Net Income

$7M10.7% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

$30M

Free Cash Flow

-$16M

Stock-Based Comp.

$470,000

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.5B

Stockholders' Equity

$463M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$58M	+14.5%
Gross Profit	$37M	$37M	-0.7%
Operating Income	$19M	$23M	-17.6%
Net Income	$7M	$14M	-47.1%